Roche explores Swiss franc five million outsourcing
Swiss drug maker F Hoffmann La Roche is in talks with leading Indian drug makers to source raw materials worth Swiss Francs five million a year for its entire range of products.

Elder signs marketing tie-up with Japanese cos for lifestyle drugs
City-based Elder Pharmaceuticals has entered into in-licensing agreements with two Japanese pharmaceutical companies — Tanabe Seiyaku and Fujisawa.

Novartis explores marketing, R&D collaborations in India
SWISS drug major Novartis is exploring collaborations with Indian pharmaceutical companies in the areas of licensing, R&D and marketing.

Ranbaxy launches first branded product in UK
Ranbaxy Laboratories Limited (Ranbaxy), announced the launch of its first branded prescription medicine, Visclair tablets 100mcg (mecysteine HCL) in the UK.

Lupin, Baxter sign marketing tie-up for ceftriaxone
LUPIN Ltd announced that the company has entered into an agreement with Baxter Healthcare Corporation, a global medical products company headquartered in the United States, whereby Baxter will exclusively distribute the company’s generic version of ceftriaxone sterile vials for injection in the US.

ACD/Labs identifies India as potential market for IT in pharma R&D
Research and development in the pharmaceutical or life sciences sector is a matter of time and the industry needs to gear up to meet the challenges.